109490 ⎘
Coculture with; Conditioned medium produced by tumour cells
COMPOSITIONS AND METHODS FOR GENERATING NEO-ANTIGEN REACTIVE TUMOR INFILTRATING LYMPHOCYTES
#2IMMUNE CELL ORGANOID CO-CULTURES
#3Multispecific antigen binding proteins for tumor-targeting of NK cells and use thereof
#4IDENTIFICATION OF HIGHLY IMMUNOSUPRESIVE TREG POPULATION IN TUMOR MICROENVIRONMENTS
#5NOVEL CD4+ TUMOR INFILTRATING LYMPHOCYTES FOR THE TREATMENT OF CANCER
#6MODIFIED K562 FEEDER CELL LINE EXPRESSING FACTORS THAT ENHANCE THE ACTIVATION AND PROLIFERATION OF NATURAL KILLER CELLS AND A METHOD FOR ITS PRODUCTION
#7TARGETING COMMON SOMATIC MUTATIONS IN BREAST CANCER WITH NEO-ANTIGEN SPECIFIC ADOPTIVE T CELL THERAPY
#8METHOD OF PREPARING AND EXPANDING A POPULATION OF IMMUNE CELLS FOR CANCER THERAPY, POTENCY ASSAY FOR TUMOR RECOGNITION, BIOLOGICAL VACCINE PREPARATION AND EPITOPETARGET FOR ANTIBODIES
#9METHOD OF TREATING PARKINSON'S DISEASE WITH EXPANDED NATURAL KILLER CELLS
#10METHODS AND SYSTEMS FOR IMMUNOME PROFILING FOR CANCER DIAGNOSIS AND TREATMENT PROGNOSIS
#11METHODS OF USING TUMOR INFILTRATING LYMPHOCYTES IN DOUBLE-REFRACTORY MELANOMA
#12COMPOSITIONS AND METHODS FOR TARGETED TREATMENT AND IMAGING OF CANCER TUMORS
#13METHODS OF ISOLATING AND ENHANCING POPULATIONS OF TUMOR-REACTIVE LYMPHOCYTES
#14METHOD FOR ENRICHING TUMOR INFILTRATING LYMPHOCYTES
#15METHODS FOR IDENTIFYING AND USING ALLOGENEIC TUMOR INFILTRATING LYMPHOCYTES TO TREAT CANCER
#16ENGINEERED ANTIGEN PRESENTING CELLS AND USES THEREOF
#17CYTOKINE ASSOCIATED TUMOR INFILTRATING LYMPHOCYTES COMPOSITIONS AND METHODS
#18EXPANSION OF HUMAN GROUP 2 INNATE LYMPHOID CELLS AND METHODS OF USE THEREOF
#19METHODS FOR CULTURING STEM AND PROGENITOR CELLS
#20NON-CYTOTOXIC MODIFIED CELLS AND USE THEREOF
#21PROCESSING OF TUMOR INFILTRATING LYMPHOCYTES
#22COMPOSITIONS AND METHODS FOR EXPANDING EX VIVO NATURAL KILLER CELLS AND THERAPEUTIC USES THEREOF
#23METHODS OF EXPANSION TREATMENT UTILIZING CD8 TUMOR INFILTRATING LYMPHOCYTES
#24TRANSGENIC T CELL RECEPTORS TARGETING NEOANTIGENS FOR DIAGNOSIS, PREVENTION, AND/OR TREATMENT OF HEMATOLOGICAL CANCERS
#25EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS
#26METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#27EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS
#28EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES FROM LIQUID TUMORS AND THERAPEUTIC USES THEREOF
#29METHODS OF AMPLIFYING TUMOR-REACTIVE IMMUNE POPULATIONS USING ORGANOIDS
#30METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS
#31METHOD FOR PRESERVING DEVELOPMENTAL POTENTIAL OF IMMUNE CELLS USED FOR ADOPTIVE CELLULAR THERAPIES
#32TUMOR INFILTRATION LYMPHOCYTE CULTURE MEDIUM AND APPLICATION THEREOF
#33METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS
#34COLD ATMOPSHERIC PLASMA TREATED PAN-CANCER EPITOPE PEPTIDE WITHIN THE COLLAGEN TYPE VI A-3 (COL6A3) PROTEIN AS CANCER VACCINE
#35ADJUVANT THERAPY FOR CANCER
#36COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS
#37COMPOSITION CONTAINING FEEDER CELL FOR PROLIFERATING NATURAL KILLER CELL
#38Nanobody Target MSLN and Uses in Chimeric Antigen Receptor Cell Therapy
#39Bioengineered and standardized Human Tissue Reference Controls for Validation of IHC, FISH or CISH Cancer Test Results
#40STING DEPENDENT ADJUVANTS
#41METHOD FOR OBTAINING TUMOR-HYPOXIA EDUCATED REGENERATIVE MACROPHAGES AND USE THEREOF IN REGENERATIVE MEDICINE
#42METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS
#43METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES
#44COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND DENDRITIC CELLS
#45TUMOR-INFILTRATING LYMPHOCYTES WITH MEMBRANE BOUND INTERLEUKIN 15 AND USES THEREOF
#46DIAGNOSTIC METHODS
#47METHODS OF PREPARING AND EXPANDING TYPE I INNATE LYMPHOID CELLS AND THERAPEUTIC USES THEREOF
#48METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS
#49DEVICES AND METHODS FOR ISOLATING TUMOR INFILTRATING LYMPHOCYTES AND USES THEREOF
#50ARTIFICIAL ANTIGEN-PRESENTING CELL
#51A PLATFORM TO OBTAIN MONOCLONAL ANTIBODIES DIRECTED AGAINST PROCESSED TUMOR-SPECIFIC ANTIGENS
#52METHOD FOR BUILDING CO-CULTURE MODEL FOR CACO-2/RAW-264.7 CELLS INDUCED BY LIPOPOLYSACCHARIDES AND APPLICATION OF CO-CULTURE MODEL
#53METHOD FOR IDENTIFYING ANTI-CANCER AGENTS USING AN IN VITRO CELL CULTURE SYSTEM THAT MAINTAINS CANCER CELL STEMNESS
#54DEVICES AND METHODS FOR ISOLATING TUMOR INFILTRATING LYMPHOCYTES AND USES THEREOF
#55METHODS AND COMPOSITIONS FOR STIMULATING GAMMA DELTA T CELLS
#56B-CELL CULTIVATION METHOD
#57LUNG CANCER MODELING USING NORMAL LUNG ORGANOID WITH LUNG CANCER CELLS
#58METHOD FOR DETECTING IMMUNE EFFICACY AND METHOD OF TREATING A CANCER
#59METHODS FOR IDENTIFYING MODULATORS OF NATURAL KILLER CELL INTERACTIONS
#60MODIFIED CELLS OF LEUKEMIC ORIGIN AND A PD-L1 ANTIBODY FOR ENHANCING THE EFFICACY OF CANCER CELL THERAPY
#61Expansion Of Peripheral Blood Lymphocytes (PBLS) From Peripheral Blood
#62GENERATION OF TUMOR IMMUNITY USING ASTROCYTES AND ASTROCYTE-DENDRITIC CELL COMBINATIONS
#63ENHANCING ANTI-TUMOR RESPONSE IN MELANOMA CELLS WITH DEFECTIVE STING SIGNALING
#64T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS
#65COLD PLASMA TREATMENT MEDIATED TUMOR SPECIFIC T CELL THERAPY
#66COMPOSITIONS INCLUDING EX VIVO ARMED T CELLS WITH MULTI-SPECIFIC ANTIBODIES AND USES THEREOF
#67PREFERENTIAL GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTES
#68ENHANCED EXPANSION AND CYTOTOXICITY OF ENGINEERED NATURAL KILLER CELLS AND USES THEREOF
#69DELIVERY DEVICES
#70T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS
#71NATURAL KILLER (NK) CELL COMPOSITIONS AND METHODS FOR GENERATING SAME
#72NK CELLS AND USES THEREOF FOR TREATMENT OF MICROBIAL INFECTIONS
#73Methods of preparing anti-human papillomavirus antigen T cells
#74GLYPICAN-2-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#75ENGINEERED REGULATORY T CELL
#76Compositions and Methods for Anti-TnMUC1 Gold CAR T-cells
#77EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES FROM LIQUID TUMORS AND THERAPEUTIC USES THEREOF
#78ENGINEERED FIBROBLASTS AS CELL THERAPY TO TREAT CANCER VIA TUMOR STROMA STABILIZATION
#79METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND CYTOTOXICITY OF NATURAL KILLER CELLS
#80Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof
#81EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS FOR TREATMENT OF CANCER
#82METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS
#83IN VITRO MODEL FOR A TUMOR MICROENVIRONMENT
#84METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#85METHODS FOR CULTURING STEM AND PROGENITOR CELLS
#86PDL1 POSITIVE NK CELL CANCER TREATMENT
#87METHODS AND COMPOSITIONS FOR SELECTING TUMOR INFILTRATING LYMPHOCYTES AND USES OF THE SAME IN IMMUNOTHERAPY
#88METHODS FOR GENERATION OF TUMOR ORGANOID-FISHED T CELLS AND IDENTIFICATION OF ANTI-TUMOR T CELL RECEPTORS
#89METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE
#90FABRICATION OF A BIOMIMETIC PLATFORM SYSTEM AND METHODS OF USE
#91POROUS HOLLOW FIBER MEMBRANE AND METHODS OF USING IT TO SELECT IMMUNE CHECKPOINT INHIBITOR
#92ANTI-RABBIT CD19 ANTIBODIES AND METHODS OF USE
#93METHODS OF USING TUMOR INFILTRATING LYMPHOCYTES IN DOUBLE-REFRACTORY MELANOMA
#94Generation of organoid-primed T (opT) cells with memory phenotype
#95METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING INFLAMMATORY DISEASES
#96METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY
#97Methods of preparing anti-human papillomavirus antigen T cells
#98Methods of preparing anti-human papillomavirus antigen T cells
#99Methods of preparing anti-human papillomavirus antigen t cells
#100Methods for screening for cancer targets
#101METHODS AND COMPOSITIONS FOR STIMULATION OF CHIMERIC ANTIGEN RECEPTOR T CELLS WITH HAPTEN LABELLED CELLS
#102METHOD FOR ENHANCING IMMUNE FUNCTION OF IMMUNE CELL AND IMMUNE CELL LINE PRODUCED USING THE SAME
#103CELL LINKERS FOR HETEROTYPIC CELL SPHEROIDS
#104Compositions and methods of enhancing anti-tumor response using hybrid neutrophils
#105METHOD FOR PRODUCING REGENERATED T CELL POPULATION VIA iPS CELLS
#106PRODUCTION AND SELECTION OF TUMOR UBER REACTIVE IMMUNE CELLS (TURICS)
#107IMMUNE CELL ORGANOID CO-CULTURES
#108SPHERICAL 3D TUMOR SPHEROID
#109ENHANCING ANTI-TUMOR RESPONSE IN MELANOMA CELLS WITH DEFECTIVE STING SIGNALING
#110METHOD FOR PRODUCING T CELLS MODIFIED BY CHIMERIC ANTIGEN RECEPTOR
#111Engineered antigen presenting cells and uses thereof
#112Methods of using tumor infiltrating lymphocytes in double-refractory melanoma
#113Supernatant from a coculture of macrophages and irradiated leukocytes, for controlling tumour progression or restoring anti-tumor immunity
#114B-CELL CULTIVATION METHOD
#115Methods of preparing anti-human papillomavirus antigen T cells
#116Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
#117TISSUE-ENGINEERED THREE-DIMENSIONAL MODEL FOR TUMOR ANALYSIS
#118PATIENT-SPECIFIC CANCER THERAPY SCREENING AND METHODS OF TREATMENT
#119UNIVERSAL ANTIGEN PRESENTING CELLS AND USES THEREOF
#120METHODS FOR ACTIVATING IMMUNE CELLS
#121Human pluripotent stem cell-derived brain organoids for cancer modeling and drug screening
#122T-cells expressing anti-LIV1 chimeric antigen receptor
#123EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES FROM LIQUID TUMORS AND THERAPEUTIC USES THEREOF
#124Compositions for expanding natural killer cells
#125Compositions and methods for targeted treatment and imaging of cancer or tumors
#126Compositions and methods for in vitro activation and expansion of serial killer T cell populations and passive immunization of a cancer patient with tumor cell killing cells
#127Methods of isolating neoantigen-specific T cell receptor sequences
#128TUMOR ANTIGEN PRESENTATION INDUCER CONSTRUCTS AND USES THEREOF
#129Gamma delta T cells and a method of augmenting the tumoricidal activity of the same
#130Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
#131In vitro model for a tumor microenvironment
#132MR1 restricted T cell receptors for cancer immunotherapy
#133Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer
#134Diagnostic methods
#135Non-cytotoxic modified cells and use thereof
#136Methods of using tumor infiltrating lymphocytes in double-refractory melanoma
#137AN EX VIVO METHOD FOR TESTING CELLULAR RESPONSEIVENESS OF PRIMARY CELL POPULATIONS TO A DRUG OR COMBINATION OF DRUGS
#138Generation of cancer stem cells and use thereof
#139NOVEL CHICKEN EGG-BASED METASTASIS MODEL FOR CANCER
#140POPULATION OF AMNIOCYTES HAVING PHAGOCYTIC ACTIVITY AGAINST PATHOLOGICAL CELLS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF IN THE MEDICAL FIELD
#141METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS
#142B-cell cultivation method
#143Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming
#144Therapeutic methods using erythrocytes
#145Tissue-engineered three-dimensional model for tumor analysis
#146GENERATION OF CYTOTOXIC TUMOR SPECIFIC CELL LINES AND USES THEREOF
#147Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
#148METHOD FOR THE INDUCTION AND EXPANSION OF NATURAL KILLER CELLS DERIVED FROM PERIPHERAL BLOOD MONONUCLEAR CELLS
#149HYDROGEL-BASED MICROFLUIDIC CHIP FOR CO-CULTURING CELLS
#150DEVICE WITH MULTIPLE MICROENVIRONMENTS AND METHODS THEREOF
#151Combination immune therapy and cytokine control therapy for cancer treatment
#152COMPOSITIONS AND METHODS OF TREATING CANCER
#153Devices for cell culture and methods of making and using the same
#154Methods of producing modified natural killer cells and methods of use
#155EXPANSION OF ALLOANTIGEN-REACTIVE REGULATORY T CELLS
#156In vitro model for a tumor microenvironment
#1573D tissue-engineered bone marrow for personalized therapy and drug development
#158POLYVALENT ANTI-TUMOR FIBROBLAST VACCINE
#159A METHOD TO UP-REGULATE CANCER STEM CELL MARKERS FOR THE GENERATION OF ANTIGEN SPECIFIC CYTOTOXIC EFFECTOR T CELLS
#160DIVIDABLE SURFACES FOR CELL CULTURING
#161In vivo priming of natural killer cells
#162Cell culture devices for biomimetic and pathomimetic cell cultures
#163MATERIAL FOR CELL CULTIVATION, PRODUCTION METHODS AND USES THEREOF
#164Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming
#165COMPOSITE TISSUE CANCER VACCINE
#166Composition of stem cells having highly expressed FAS ligand
#167Regulatory B cells (tBREGS) and their use
#1683D tissue-engineered bone marrow for personalized therapy and drug development
#169Generation of cytotoxic tumor specific cell lines and uses thereof
#170Cell-to-cell communication without exchange of mediating diffusible factors or using any physical contact between cells
#171TREATMENT OF BONE-RELATED CANCERS USING PLACENTAL STEM CELLS
#172Allogenic mesendritic vector for ovarian cancer
#173Method for inducing fusion of dendritic cell with tumour cell
#174Human myeloid derived suppressor cell cancer markers
#175Methods and Compositions for Treating or Diagnosing Melanoma
#176Method for the induction and expansion of natural killer cells derived from peripheral blood mononuclear cells
#177In vitro model for a tumor microenvironment
#178Expansion of alloantigen-reactive regulatory T cells
#179Culture based screening assay and methods of use thereof to identify agents which modulate tumor development, invasion and differentiation
#180Kit and method for the capture of tumor cells
#181Direct differentiation of cardiomyocytes from embryonic stem cells
#182Regenerated tissue comprising a stratified structure of epithelial cells
#183Reducer of immunosuppression by tumor cell and antitumor agent using the same
#184In vitro tumor angiogenesis model
#185Regulatory B cells (tBREGS) and their use
#186Human myeloid derived suppressor cell cancer markers
#187REPROGRAMMING CANCER CELLS
#188Conditioned medium and proliferated cell lines produced therefrom
#189Treatment of astrocytes-tumor cells inhibitors of endothelin receptors
#190Methods of evaluating a test agent in a diseased cell model
#191Methods of producing proteins in Chinese hamster ovary (CHO) cells
#192Human bone marrow microenvironments and uses thereof
#193Treatment of bone-related cancers using placental stem cells
#194Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof
#195Kit and method for the capture of tumor cells
#196ANTI-TUMORAL CELLS
#197Culture based screening assay and methods of use thereof to identify agents which modulate tumor development, invasion and differentiation
#198DIFFERENTIATED IMMORTALISED CELL LINES CAPABLE OF PRODUCING ALBUMIN AND BLOOD COAGULATION FACTORS, METHODS OF PREPARING THEREOF FROM A LEUKAEMIA CELL LINE AND USES THEREOF
#199Preserved compositions of activated NK cells and methods of using the same
#200Culturing embryonic stem cells, embryonic stem-like cells, or induced pluripotent stem cells with a Muc1 or Muc1* ligand
#201REDUCER OF IMMUNOSUPPRESSION BY TUMOR CELL AND ANTITUMOR AGENT USING THE SAME
#202Methods of evaluating a test agent in a diseased cell model
#203Method for preparing cell populations with anti-tumor immune response activity
#204TUMOUR-CELL-FIXING CELLS
#205Methods for the preparation of fibroblasts
#206Disease model incorporation into an artificial immune system (AIS)
#207In vitro tumor angiogenesis model
#208Prostacyclin directed differentiation of cardiomyocytes from human embryonic stem cells
#209USE OF CELLS DERIVED FROM ADIPOSE TISSUE FOR THE PREPARATION OF AN ANTI-TUMOR MEDICAMENT
#210STEM CELL TARGETING OF CANCER, METHODS AND COMPOSITIONS THEREFOR
#211Disease model incorporation into an artificial immune system (AIS)
#212Proliferated cell lines and uses thereof
#213Human Prostate Cancer Cell Factor(s) that Induce Stem Cell Commitment and Osteogenesis
#214Direct differentiation of cardiomyocytes from human embryonic stem cells
#215In vitro tumor angiogenesis model
#216Disease model incorporation into an artificial immune system (AIS)
#217Method for preparing an extracellular matrix and its use for tumor cell culture
#218Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic T lymphocyte activity
#219Method and composition for skin grafts
#220Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
#221In vitro induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
#222In vitro synthesis of a layered cell sorted tissue
#223Regulation of human pluripotential cells by bone morphogenetic protein 2 antagonists
#224Method for recloning Chinese hamster ovary (CHO) cells
#225Method for inducing cytotoxic T lymphocyte
#226Dendritic cell preparation and preparation method thereof